As the field of weight loss medications continues to evolve, regulatory agencies play a critical role in evaluating the safety, efficacy, and appropriate use of these novel treatments, ultimately shaping the landscape of obesity care
Side effects often peak at this dose increase, possibly because it represents the largest percentage jump in the escalation (a 50% increase from 5 mg to 7.5 mg)
Perform hand hygiene and don appropriate PPE (gloves, gown, mask) in accordance with institutional SOP
The primary antibodies used in this study included glutamate cysteine ligase catalytic subunits (GCLC), glutamate cysteine ligase modifier subunit (GCLM), glutathione synthetase (GSS), peroxisome proliferator-activated receptor-gamma coactivator (PGC)1alpha (PGC1), peroxisome proliferator-activated receptor (PPAR), mitochondrial ATP synthase F1 subunit alpha (ATP5A), PTEN-induced kinase 1 (PINK1)
Receptors 4: 2
SHAZEL GHARBI AND NAEL GHARBI The MD Brothers are Drs